Extracellular Guanosine and Guanine Nucleotides Decrease Viability of Human Breast Cancer SKBR-3 Cells

Biol Pharm Bull. 2024 Jan 1;47(1):14-22. doi: 10.1248/bpb.b23-00402. Epub 2023 Oct 25.

Abstract

Though the physiological effects of adenosine and adenine nucleotides on purinergic receptors in cancer cells have been well studied, the influence of extracellular guanosine and guanine nucleotides on breast cancer cells remains unclear. Here, we show that extracellular guanosine and guanine nucleotides decrease the viability and proliferation of human breast cancer SKBR-3 cells. Treatment with guanosine or guanine nucleotides increased mitochondrial production of reactive oxygen species (ROS), and modified the cell cycle. Guanosine-induced cell death was suppressed by treatment with adenosine or the equilibrium nucleoside transporter (ENT) 1/2 inhibitor dipyridamole, but was not affected by adenosine receptor agonists or antagonists. These results suggest that guanosine inhibits adenosine uptake through ENT1/2, but does not antagonize adenosine receptors. In contrast, guanosine triphosphate (GTP)-induced cell death was suppressed not only by adenosine and dipyridamole, but also by the A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA), suggesting that GTP-induced cell death is mediated in part by an antagonistic effect on adenosine A1 receptor. Thus, both guanosine and GTP induce apoptosis of breast cancer cells, but via at least partially different mechanisms.

Keywords: adenosine; breast cancer; cell death; guanosine; guanosine triphosphate (GTP).

MeSH terms

  • Adenosine / metabolism
  • Adenosine / pharmacology
  • Breast Neoplasms* / drug therapy
  • Dipyridamole
  • Female
  • Guanine Nucleotides* / metabolism
  • Guanine Nucleotides* / pharmacology
  • Guanosine / pharmacology
  • Guanosine Triphosphate / pharmacology
  • Humans

Substances

  • Guanine Nucleotides
  • Guanosine
  • Guanosine Triphosphate
  • Adenosine
  • Dipyridamole